Related by context. Frequent words. (Click for all words.) 70 CONTAINS FORWARD LOOKING STATEMENTS 69 Presents Positive 69 IS FOR INFORMATIONAL 68 Completes Enrollment 66 Joins OTCQX 66 Reduces Risk 65 Drug Candidate 65 Regains Compliance 65 Recombinant Human 65 Inc Therapeutic Competitors 65 folgenden Meldung ist nicht 65 FDA Clears 64 Single Dose 64 Clinical Trial Results 64 Patient Enrollment 64 FDA Accepts 64 Announces Initiation 64 Receives FDA Clearance 63 Files Shelf Registration Statement 63 Advancing Drugs 63 AT HTTP :/ 63 Inc. Nasdaq IMGN 63 Q2 Loss Narrows 63 Stock Downgraded 62 Well Tolerated 62 Generic Version 62 Q2 Loss Widens 62 EARNINGS SOURCE 62 Phase III Clinical Trial 62 Initiates Phase 62 Significantly Reduces 62 Fibrocell Science Inc. 62 Develop Novel 62 refractory chronic lymphocytic 62 Receives Positive 61 Stock Upgraded 61 IIROC Resume 61 Completes Tender Offer 61 Receives Patent 61 PYMX 61 Patent Issued 61 Patent Covering 61 Preclinical Data 61 Announces Stockholder Approval 61 Inhibits 61 Webcast Annual Meeting 61 Alert Technicals Showing Bullish 61 registered trademark Reg 60 Provides Preliminary 60 www.labopharm.com 60 PROFILE CO 60 die Verivox GmbH sondern 60 Announces Publication 60 Voluntary Recall 60 Awarded Patent 60 Announces Organizational Changes 60 www.cardiome.com 60 II Clinical Trial 60 Files Patent 60 Hold Fourth Quarter 60 Introduces Enhanced 60 Receives Notice 60 Panzem R 59 submitted Biologics License 59 www.ziopharm.com 59 Announces Successful Completion 59 IIROC Halt 59 www.combinatorx.com 59 &Amp; 59 Low Dose 59 Reports Positive 59 liposomal formulation 59 Elderly Patients 59 Explore Strategic Alternatives 59 Files Annual Report 59 Significantly Increases 59 Metastatic Melanoma 59 Completes Financing 59 Application MAA 59 Extends Tender Offer 59 Announces Signing 59 www.delcath.com 59 Company Nasdaq PRGO 59 Recalled Due 59 Receives CE 59 Introduces Next Generation 58 Monoclonal Antibody 58 Director Shareholding 58 FDA Warns 58 Provides Comprehensive 58 Announces Immediate Availability 58 Paris EURONEXT SAN 58 Declares Quarterly Dividends 58 Introduces Revolutionary 58 www.antigenexpress.com 58 Complete Merger 58 Voreloxin 58 Clinical Trials Update 58 www.polymedix.com 58 verantwortlich 58 Launches Next Generation